Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients
Gespeichert in:
| Veröffentlicht in: | Journal of neuroimmunology 2008-11, Vol.204 (1), p.155-156 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 156 |
|---|---|
| container_issue | 1 |
| container_start_page | 155 |
| container_title | Journal of neuroimmunology |
| container_volume | 204 |
| creator | Houff, Sidney A Berger, Joseph Major, Eugene O |
| description | |
| doi_str_mv | 10.1016/j.jneuroim.2008.05.007 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69927501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0165572808001574</els_id><sourcerecordid>69927501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c452t-b2f1ec1c07b9e38544f86f34ea51dfb1f9d33ffd925ac39d7d4a97cb11df0ea83</originalsourceid><addsrcrecordid>eNqFUsuO1DAQjBCIHRZ-YeUTtwTbiZP4gkCr5SGNQOJxthynjRycOLgdxPIP_DMOMwiJy55ara7qV1VRXDFaMcraZ1M1LbDF4OaKU9pXVFSUdveKA-s7XvYNZ_eLQwaKUnS8vygeIU6UMlE38mFxwSRjHe37Q_HrA-AaFgSSAjm6ZYD4hUAi2lfknU7au5_brIecJ4hIUtQLmujW5MKiPYEfawTEnJA1Bus8IAmWDD6EkRjwnuA2rGHdvN4Zf4rz5pNbPRA0HmJAh2TNVVgSPi4eWO0RnpzjZfH51c2n6zfl8f3rt9cvj6VpBE_lwC0DwwztBgl1L5rG9q2tG9CCjXZgVo51be0oudCmlmM3Nlp2ZmC5SkH39WXx9NQ3L_1tA0xqdrivqxcIG6pWSt4Jyu4EMikY47LNwPYENPkijGDVGt2s461iVO2KqUn9VUztiikqVFYsE6_OE7ZhhvEf7SxRBrw4ASA_5LuDqNDkZxkYXQST1Bjc3TOe_9fCeLc4o_1XuAWcwhazmPkahVxR9XH3zW4b2u-W6Zr6NxP6xRY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19511296</pqid></control><display><type>article</type><title>Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Houff, Sidney A ; Berger, Joseph ; Major, Eugene O</creator><creatorcontrib>Houff, Sidney A ; Berger, Joseph ; Major, Eugene O</creatorcontrib><identifier>ISSN: 0165-5728</identifier><identifier>EISSN: 1872-8421</identifier><identifier>DOI: 10.1016/j.jneuroim.2008.05.007</identifier><identifier>PMID: 19117088</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Allergy and Immunology ; Antibodies, Monoclonal - pharmacology ; Antibodies, Monoclonal - therapeutic use ; Antibodies, Monoclonal, Humanized ; Blood Cells - drug effects ; Blood Cells - metabolism ; Humans ; Multiple Sclerosis - blood ; Multiple Sclerosis - drug therapy ; Natalizumab ; Neurology ; Transcription, Genetic - drug effects</subject><ispartof>Journal of neuroimmunology, 2008-11, Vol.204 (1), p.155-156</ispartof><rights>Elsevier B.V.</rights><rights>2008 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c452t-b2f1ec1c07b9e38544f86f34ea51dfb1f9d33ffd925ac39d7d4a97cb11df0ea83</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0165572808001574$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19117088$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Houff, Sidney A</creatorcontrib><creatorcontrib>Berger, Joseph</creatorcontrib><creatorcontrib>Major, Eugene O</creatorcontrib><title>Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients</title><title>Journal of neuroimmunology</title><addtitle>J Neuroimmunol</addtitle><subject>Allergy and Immunology</subject><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Blood Cells - drug effects</subject><subject>Blood Cells - metabolism</subject><subject>Humans</subject><subject>Multiple Sclerosis - blood</subject><subject>Multiple Sclerosis - drug therapy</subject><subject>Natalizumab</subject><subject>Neurology</subject><subject>Transcription, Genetic - drug effects</subject><issn>0165-5728</issn><issn>1872-8421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFUsuO1DAQjBCIHRZ-YeUTtwTbiZP4gkCr5SGNQOJxthynjRycOLgdxPIP_DMOMwiJy55ara7qV1VRXDFaMcraZ1M1LbDF4OaKU9pXVFSUdveKA-s7XvYNZ_eLQwaKUnS8vygeIU6UMlE38mFxwSRjHe37Q_HrA-AaFgSSAjm6ZYD4hUAi2lfknU7au5_brIecJ4hIUtQLmujW5MKiPYEfawTEnJA1Bus8IAmWDD6EkRjwnuA2rGHdvN4Zf4rz5pNbPRA0HmJAh2TNVVgSPi4eWO0RnpzjZfH51c2n6zfl8f3rt9cvj6VpBE_lwC0DwwztBgl1L5rG9q2tG9CCjXZgVo51be0oudCmlmM3Nlp2ZmC5SkH39WXx9NQ3L_1tA0xqdrivqxcIG6pWSt4Jyu4EMikY47LNwPYENPkijGDVGt2s461iVO2KqUn9VUztiikqVFYsE6_OE7ZhhvEf7SxRBrw4ASA_5LuDqNDkZxkYXQST1Bjc3TOe_9fCeLc4o_1XuAWcwhazmPkahVxR9XH3zW4b2u-W6Zr6NxP6xRY</recordid><startdate>20081115</startdate><enddate>20081115</enddate><creator>Houff, Sidney A</creator><creator>Berger, Joseph</creator><creator>Major, Eugene O</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20081115</creationdate><title>Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients</title><author>Houff, Sidney A ; Berger, Joseph ; Major, Eugene O</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c452t-b2f1ec1c07b9e38544f86f34ea51dfb1f9d33ffd925ac39d7d4a97cb11df0ea83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Allergy and Immunology</topic><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Blood Cells - drug effects</topic><topic>Blood Cells - metabolism</topic><topic>Humans</topic><topic>Multiple Sclerosis - blood</topic><topic>Multiple Sclerosis - drug therapy</topic><topic>Natalizumab</topic><topic>Neurology</topic><topic>Transcription, Genetic - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Houff, Sidney A</creatorcontrib><creatorcontrib>Berger, Joseph</creatorcontrib><creatorcontrib>Major, Eugene O</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroimmunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Houff, Sidney A</au><au>Berger, Joseph</au><au>Major, Eugene O</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients</atitle><jtitle>Journal of neuroimmunology</jtitle><addtitle>J Neuroimmunol</addtitle><date>2008-11-15</date><risdate>2008</risdate><volume>204</volume><issue>1</issue><spage>155</spage><epage>156</epage><pages>155-156</pages><issn>0165-5728</issn><eissn>1872-8421</eissn><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>19117088</pmid><doi>10.1016/j.jneuroim.2008.05.007</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0165-5728 |
| ispartof | Journal of neuroimmunology, 2008-11, Vol.204 (1), p.155-156 |
| issn | 0165-5728 1872-8421 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_69927501 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Allergy and Immunology Antibodies, Monoclonal - pharmacology Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Humanized Blood Cells - drug effects Blood Cells - metabolism Humans Multiple Sclerosis - blood Multiple Sclerosis - drug therapy Natalizumab Neurology Transcription, Genetic - drug effects |
| title | Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T22%3A21%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Response%20to%20Linberg%20et%20al.%20Natalizumab%20alters%20transcriptional%20expression%20profiles%20of%20blood%20cell%20subpopulations%20of%20multiple%20sclerosis%20patients&rft.jtitle=Journal%20of%20neuroimmunology&rft.au=Houff,%20Sidney%20A&rft.date=2008-11-15&rft.volume=204&rft.issue=1&rft.spage=155&rft.epage=156&rft.pages=155-156&rft.issn=0165-5728&rft.eissn=1872-8421&rft_id=info:doi/10.1016/j.jneuroim.2008.05.007&rft_dat=%3Cproquest_cross%3E69927501%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19511296&rft_id=info:pmid/19117088&rft_els_id=1_s2_0_S0165572808001574&rfr_iscdi=true |